Company / Revenue per Share
Crinetics Pharmaceuticals, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.08
FY2025
5-year range
$0.01 / $0.09
FY2021-FY2025
Trend
+620.2%
vs FY2024
Sector context
#136 of 154
Health Care
What the data says
Revenue per Share changed +620% YoY in FY2025, a notable deviation from the 9-year average annual change of +2552%.
Based on SEC 10-K filings.
0.08 in FY2025 with a 5-year CAGR of -4.3%.
Improved from $0.07 to $0.08 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -2.9%
- 5-Year CAGR
- -4.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 154This company $0.08 Sector average $15.09
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 620.2% year-over-year.
- Ranks #136 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2019.
- Lowest revenue per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.08 | +620.2% |
| FY2024 | $0.01 | -83.8% |
| FY2023 | $0.07 | -21.4% |
| FY2022 | $0.09 | +288.2% |
| FY2021 | $0.02 | -77.4% |
| FY2020 | $0.10 | -99.9% |
| FY2019 | $84.99 | +22260.3% |
| FY2018 | $0.38 | -74.5% |
| FY2017 | $1.49 | +156.0% |
| FY2016 | $0.58 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026